Blackgate
System control / privileged execution boundaries
This page records only information safe for public release. It does not expose active hypotheses, report details or unpatched behavior.
SUCCESSOR TO OP-001 / ACHERONSystem control / privileged execution boundaries
Pipeline trust / native execution boundaries
Runtime internals / server execution boundaries
Confirm one critical RCE zero-day on each research front.
CRITICAL RCE ZERO-DAY
CRITICAL RCE ZERO-DAY
CRITICAL RCE ZERO-DAY
A high-severity issue affecting the confidentiality and integrity of protected responses was reported. Technical details remain restricted during coordinated review.
A high-severity availability issue capable of affecting service-wide capacity without authentication was reported. Technical details remain restricted during coordinated review.
A critical issue reachable without authentication could lead to server compromise across multiple framework integrations. The report was marked duplicate, and technical details remain restricted during coordinated disclosure.
Titles describe only the broad impact area without naming affected products or exposing reproduction details.
5 public entries / latest first
A critical report with impact across multiple framework integrations was marked duplicate. The result does not satisfy the Nullcrown RCE objective, which remains open. Technical details remain restricted during coordinated disclosure.
The Nullcrown front produced a high-severity availability issue reachable without authentication. Technical details remain restricted during coordinated review.
The program requested more information on the first Nullcrown report, and the requested evidence was supplied the same day.
The Nullcrown front produced a high-severity confidentiality and integrity issue. Technical details remain restricted during coordinated review.
Three isolated research fronts entered active analysis under the Erebus harness. Each front carries one primary objective: confirm a critical remote-code-execution zero-day.
Public CVEs, advisories and writeups will be linked here after disclosure.
VYNTRA RESEARCH